Clinical Insight on GPX4, Ferritin, and Caspase-3 as Markers of Ferrotopsis Resistance in Endometriosis and Adenomyosis: A Narrative Review

In: Indonesian Journal of Obstetrics & Gynecology Science · 2026 · vol. 9(3) , pp. 583 · doi:10.24198/obgynia.v9i3.1063 · W7233740675
Review OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-19 ⓘ

This narrative review synthesizes evidence on GPX4, ferritin, and caspase-3 as markers of ferroptosis resistance and apoptosis in adenomyosis, concluding that current preclinical data lack sufficient clinical validation for routine diagnostic or therapeutic application.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-19 · read from full text ⓘ

This narrative review synthesizes current evidence regarding the molecular mechanisms of ferroptosis and apoptosis in adenomyosis, specifically examining the roles of GPX4, ferritin, and caspase-3. The authors highlight that while altered expression of these markers is documented in tissue-based investigations, their translational relevance remains limited due to a lack of validation in well-characterized clinical cohorts. The paper explicitly notes that existing data are predominantly derived from experimental, preclinical, and ex vivo studies rather than robust human trials. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective: To explore the clinical relevance of ferritin and GPX4 as biomarkers of ferroptosis resistance and caspase-3 as a marker of apoptosis in adenomyosis.Methods: A narrative review was conducted to synthesize current evidence on the molecular mechanisms of ferroptosis and apoptosis in adenomyosis, including the roles of GPX4, ferritin, and caspase-3 in endometrial cell survival, lesion persistence, and resistance to cell death pathways.Discussion: Altered expression of ferroptosis-associated markers, including GPX4, ferritin, and lipid peroxidation products, has been reported predominantly in tissue-based investigations. However, the translational relevance of these findings remains limited. Although ferroptosis-related biomarkers demonstrate biological plausibility for diagnostic and therapeutic applications, the current body of evidence is largely derived from experimental, preclinical, and ex vivo studies, with insufficient validation in well-characterized clinical cohorts.Conclusion: Further well-designed clinical investigations are required before ferroptosis-targeted approaches can be considered for routine clinical application.Tinjauan Klinis atas GPX4, Ferritin, dan Caspase-3 sebagai Penanda Resistensi Ferroptosis pada Endometriosis dan Adenomiosis: Suatu Tinjauan NaratifAbstrakTujuan: Penelitian ini bertujuan mengengeksplorasi relevansi klinis ferritin dan GPX4 sebagai biomarker resistensi terhadap ferroptosis serta caspase-3 sebagai penanda apoptosis pada adenomiosis.Metode: Penelitian ini menggunakan tinjauan naratif dilakukan dengan mensintesis bukti terkini tentang mekanisme molekuler ferroptosis dan apoptosis pada adenomiosis, termasuk peran GPX4, ferritin, dan caspase-3 dalam kelangsungan hidup sel endometrium, persistensi lesi, dan resistensi terhadap jalur kematian sel.Diskusi: Penelitian ini menggunakan perubahan ekspresi penanda terkait ferroptosis, termasuk GPX4, ferritin, dan produk peroksidasi lipid, telah dilaporkan terutama dalam investigasi berbasis jaringan. Namun, relevansi translasional dari temuan ini masih terbatas. Meskipun biomarker terkait ferroptosis menunjukkan plausibilitas biologis untuk aplikasi diagnostik dan terapeutik, bukti saat ini sebagian besar berasal dari studi eksperimental, praklinis, dan ex vivo, dengan validasi yang tidak memadai dalam kohort klinis yang terkarakterisasi dengan baik.Kesimpulan: Diperlukan investigasi klinis lebih lanjut yang dirancang dengan baik sebelum pendekatan yang ditargetkan pada ferroptosis dapat dipertimbangkan untuk aplikasi klinis rutin.
Full text 7,060 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Objective: To explore the clinical relevance of ferritin and GPX4 as biomarkers of ferroptosis resistance and caspase-3 as a marker of apoptosis in adenomyosis.

Methods

A narrative review was conducted to synthesize current evidence on the molecular mechanisms of ferroptosis and apoptosis in adenomyosis, including the roles of GPX4, ferritin, and caspase-3 in endometrial cell survival, lesion persistence, and resistance to cell death pathways.

Discussion

Altered expression of ferroptosis-associated markers, including GPX4, ferritin, and lipid peroxidation products, has been reported predominantly in tissue-based investigations. However, the translational relevance of these findings remains limited. Although ferroptosis-related biomarkers demonstrate biological plausibility for diagnostic and therapeutic applications, the current body of evidence is largely derived from experimental, preclinical, and ex vivo studies, with insufficient validation in well-characterized clinical cohorts.

Conclusion

Further well-designed clinical investigations are required before ferroptosis-targeted approaches can be considered for routine clinical application. Tinjauan Klinis atas GPX4, Ferritin, dan Caspase-3 sebagai Penanda Resistensi Ferroptosis pada Endometriosis dan Adenomiosis: Suatu Tinjauan Naratif Abstrak Tujuan: Penelitian ini bertujuan mengengeksplorasi relevansi klinis ferritin dan GPX4 sebagai biomarker resistensi terhadap ferroptosis serta caspase-3 sebagai penanda apoptosis pada adenomiosis. Metode: Penelitian ini menggunakan tinjauan naratif dilakukan dengan mensintesis bukti terkini tentang mekanisme molekuler ferroptosis dan apoptosis pada adenomiosis, termasuk peran GPX4, ferritin, dan caspase-3 dalam kelangsungan hidup sel endometrium, persistensi lesi, dan resistensi terhadap jalur kematian sel. Diskusi: Penelitian ini menggunakan perubahan ekspresi penanda terkait ferroptosis, termasuk GPX4, ferritin, dan produk peroksidasi lipid, telah dilaporkan terutama dalam investigasi berbasis jaringan. Namun, relevansi translasional dari temuan ini masih terbatas. Meskipun biomarker terkait ferroptosis menunjukkan plausibilitas biologis untuk aplikasi diagnostik dan terapeutik, bukti saat ini sebagian besar berasal dari studi eksperimental, praklinis, dan ex vivo, dengan validasi yang tidak memadai dalam kohort klinis yang terkarakterisasi dengan baik. Kesimpulan: Diperlukan investigasi klinis lebih lanjut yang dirancang dengan baik sebelum pendekatan yang ditargetkan pada ferroptosis dapat dipertimbangkan untuk aplikasi klinis rutin.

Keywords

Full Text: PDFReferences Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, et al. Endometriosis. Vol. 40, Endocrine Reviews. Endocrine Society; 2019. p. 1048–79. García-Solares J, Donnez J, Donnez O, Dolmans MM. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109(3):371–9. Li B, Duan H, Wang S, Li Y. Ferroptosis resistance mechanisms in endometriosis for diagnostic model establishment. Reprod Biomed Online. 2021;43(1):127–38. Salmassi A, Acar-Perk B, Schmutzler AG, Koch K, Püngel F, Jonat W, et al. Apoptosis resistance in endometriosis. Bioimpacts. 2011;1(2):129. Ng SW, Norwitz SG, Taylor HS, Norwitz ER. Endometriosis: the role of iron overload and ferroptosis. Reproductive Sciences. 2020;27(7):1383–90. Duan Y han, Wang H lin, Liu M na, Xu T min, Zhang K. Reflections on the complex mechanisms of endometriosis from the perspective of ferroptosis. Pathology-Research and Practice. 2024;259:155353. Chapron C, Vannuccini S, Santulli P, Abrão MS, Carmona F, Fraser IS, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392–411. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16(6):651–74. Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8:F1000-Faculty. Zannoni L, Del Forno S, Raimondo D, Arena A, Giaquinto I, Paradisi R, et al. Adenomyosis and endometriosis in adolescents and young women with pelvic pain: prevalence and risk factors. Minerva Pediatr. 2020; Teicher BA. TGFβ-directed therapeutics: 2020. Pharmacol Ther. 2021;217:107666. Bulun SE, Yildiz S, Adli M, Chakravarti D, Parker JB, Milad M, et al. Endometriosis and adenomyosis: shared pathophysiology. Fertil Steril. 2023;119(5):746–50. Cousins FL, Murray A, Esnal A, Gibson DA, Critchley HOD, Saunders PTK. Evidence from a mouse model that epithelial cell migration and mesenchymal-epithelial transition contribute to rapid restoration of uterine tissue integrity during menstruation. PLoS One. 2014;9(1):e86378. Chen X, Kang R, Tang D. Ferroptosis by lipid peroxidation: the tip of the iceberg? Front Cell Dev Biol. 2021;9:646890. Iwabuchi T, Yoshimoto C, Shigetomi H, Kobayashi H. Oxidative stress and antioxidant defense in endometriosis and its malignant transformation. Oxid Med Cell Longev. 2015;2015(1):848595. Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289(22):7038–50. Tran L, Xie B, Assaf E, Ferrari R, Pipinos II, Casale GP, et al. Transcriptomic Profiling Identifies Ferroptosis-Related Gene Signatures in Ischemic Muscle Satellite Cells Affected by Peripheral Artery Disease—Brief Report. Arterioscler Thromb Vasc Biol. 2023;43(10):2023–9. Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91–8. Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1):317–31. Do Van B, Gouel F, Jonneaux A, Timmerman K, Gelé P, Pétrault M, et al. Ferroptosis, a newly characterized form of cell death in Parkinson’s disease that is regulated by PKC. Neurobiol Dis. 2016;94:169–78. Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–25. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–72. Ma T, Du J, Zhang Y, Wang Y, Wang B, Zhang T. GPX4-independent ferroptosis—a new strategy in disease’s therapy. Cell Death Discov. 2022;8(1):434. Silva FFVE, Padín-Iruegas ME, Caponio VCA, Lorenzo-Pouso AI, Saavedra-Nieves P, Chamorro-Petronacci CM, et al. Caspase 3 and cleaved caspase 3 expression in tumorogenesis and its correlations with prognosis in head and neck cancer: a systematic review and meta-analysis. Int J Mol Sci. 2022;23(19):11937. DOI: http://dx.doi.org/10.24198/obgynia.v9i3.1063 Refbacks - There are currently no refbacks. This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Source provenance

openalex
last seen: 2026-11-21T06:07:56.064915+00:00
License: CC0 · commercial use OK